Fundraising Fox

Reshape Biotech

YC W21

Copenhagen, DK · Founded 2018 · 40 employees · 8 known investors

reshapebiotech.com ↗

Reshape provides an AI-driven operating system that automates microbiology data capture and analysis for research laboratories. The platform structures experimental results and surfaces insights to help lab teams accelerate research and product development.

AI & Machine LearningBiotechDeep TechHealthtechRoboticsDenmarkEuropePartly Remote

Founders & leadership· Y Combinator alumni (W21)

Reshape Biotech was founded in 2018 by Carl-Emil Grøn Fuglesang, Magnus Nyborg Madsen, and Daniel Storgaard.

CGCarl-Emil Grøn Fuglesang
Carl-Emil Grøn FuglesangFounderCarl-Emil Grøn Fuglesang holds degrees in mechanical engineering and physics, and serves as CEO of Reshape Biotech.
MNMagnus Nyborg Madsen
Magnus Nyborg MadseninCo-founder · Chief Customer OfficerMagnus Nyborg Madsen founded Reshape Biotech to develop laboratory automation solutions. His background includes interests in robotics and automation applied to life sciences research.
DSDaniel Storgaard
Daniel StorgaardinCo-FounderDaniel Storgaard oversees product development and project management at Reshape Biotech, with responsibilities spanning quality assurance, customer engagement, financial planning, and accounting.

Investors · 8

ACME CapitalSan Francisco
Astanor VenturesLuxembourg, Grand-Duchy Of Luxembourg
FundersClubSan Francisco · $250K – $5M
Y CombinatorSan Francisco · $500K
ACMEreportedSan Francisco
R7 PartnersreportedChicago · $100K – $5M

Also in the syndicate · 2

21stBioR7

Funding

SEC filings, press & company announcements

$20M disclosed across 1 round · 2024

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 1

by search overlap
Nobelprize15 shared keywordsNobelprize.org provides open data about the Nobel Prizes and Nobel Laureates to developers through a REST API and as Linked Data (RDF/SPARQL). The data is free to use, returned in JSON or CSV, and updated alongside the main website including at the time of new Laureate announcements.

Companies competing with Reshape Biotech for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Reshape Biotech raises $20m to take AI and robotics business to USsiliconrepublic.com · Apr 2024Reshape Biotech advances global collaboration with $20M Series A - Tech.eutech.eu · Apr 2024Reshape wants to help ‘decode nature’ by automating the ‘visual’ part of lab experiments | TechCrunchtechcrunch.com · Apr 2024Reshape Biotech - $20M Early Stage Venture | Startup Introsstartupintros.com · Apr 2024Danish biotech startup secures largest seed funding round in the country's history - ArcticStartuparcticstartup.com · Feb 2023Reshape Bio Raises $8 Million to Automate Experimental Tasks and Build New Infrastructure for Food, Agriculture and Microbial Researchfinance.yahoo.com · Feb 2023In Denmark’s largest ever Seed round, Reshape Biotech bags €7.5M to build automated lab robots | Silicon Canalssiliconcanals.com · Feb 2023

Frequently asked questions

What does Reshape Biotech do?
Reshape provides an AI-driven operating system that automates microbiology data capture and analysis for research laboratories. The platform structures experimental results and surfaces insights to help lab teams accelerate research and product development.
Who founded Reshape Biotech?
Reshape Biotech was founded by Carl-Emil Grøn Fuglesang, Magnus Nyborg Madsen, Daniel Storgaard in 2018.
Who are Reshape Biotech's investors?
Reshape Biotech's investors include ACME Capital, Astanor Ventures, FundersClub, Y Combinator, ACME, R7 Partners.
How much funding has Reshape Biotech raised?
Reshape Biotech has disclosed $20M raised across 1 round.
Where is Reshape Biotech headquartered?
Reshape Biotech is headquartered in Copenhagen, DK.